Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tirzepatide versus dulaglutide Among patients in the expanded population who initiated tirzepatide or dulaglutide, the 1-year risk for the primary endpoint including all-cause mortality in the tirzepatide group was 1.4% (95% CI 1.3% to 1.6%) versus 1.8% (95% CI 1.5% to 2.0%) for dulaglutide
PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 peptide-related pathways and 150+ genetic insightsincluding variants in the GIPR (rs1800437) genes that influence how your receptors respond to tirzepatide
( : The New England Journal of Medicine) [ ]
Semaglutide and similar GLP-1 medications are designed for subcutaneous injectionmeaning into the layer of fat beneath your skin, not into muscle tissue
A 2026 analysis projected a 1.9-year gain in life expectancy with semaglutide treatment (van Sloten et al., 2026, PMID: 41800807)
